Search Results - "Morrato, Elaine H"

US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022).

Authors: Morrato, Elaine H. Campagna, Elizabeth J. LaCivita, Cynthia et al.

Source: Drug Safety. Jul2026, Vol. 49 Issue 7, p829-841. 13p.

Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies.

Authors: Treacy, Joanne Morrato, Elaine H. Horne, Robert et al.

Source: Drug Safety. Aug2024, Vol. 47 Issue 8, p733-743. 11p.

The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE).

Authors: Smith, Meredith Y. Morrato, Elaine H. Mora, Nallely et al.

Source: Drug Safety. Jul2024, Vol. 47 Issue 7, p655-671. 17p.

Family‐centred care in early intervention: Examining caregiver perceptions of family‐centred care and early intervention service use intensity.

Authors: McManus, Beth M. Murphy, Natalie J. Richardson, Zachary et al.

Source: Child: Care, Health & Development. Jan2020, Vol. 46 Issue 1, p1-8. 8p. 1 Diagram, 4 Charts.

Subjects: Attitude (Psychology), Family medicine, Medical quality control, Medical personnel, Questionnaires, Regression analysis, Parent attitudes, Cross-sectional method, Early medical intervention, Patients' families, Descriptive statistics

Applying a Commercialization-Readiness Framework to Optimize Value for Achieving Sustainability of an Electronic Health Data Research Network and Its Data Capabilities: The SAFTINet Experience.

Authors: Morrato, Elaine H. Hamer, Mika K. Sills, Marion et al.

Source: eGEMS (Generating Evidence & Methods to Improve Patient Outcomes). 2019, Vol. 7 Issue 1, p1-14. 14p.

Applying Customer Discovery Method to a Chronic Disease Self-Management Mobile App: Qualitative Study.

Authors: Mora, Nallely Arvanitakis, Zoe Thomas, Merly et al.

Source: JMIR Formative Research; 2023, Vol. 7 Issue 1, p1-13, 13p

Bringing it home: expanding the local reach of dissemination and implementation training via a university-based workshop.

Authors: Morrato, Elaine H. Rabin, Borsika Proctor, Jeff et al.

Source: Implementation Science. Jul2015, Vol. 10 Issue 1, p1-12. 12p.

Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved.

Authors: Morrato, Elaine H. Smith, Meredith Y.

Source: Therapeutics & Clinical Risk Management. 2015, Vol. 11, p339-348. 10p.

Fostering innovation at Academic Medical Centers: The Case of University of Colorado Anschutz Medical Campus.

Authors: Benam, Cigdem H. Baler, Gali Duke, Richard et al.

Source: Journal of Clinical & Translational Science; Jul2021, Vol. 5 Issue 1, p1-7, 7p

I-Corps@NCATS trains clinical and translational science teams to accelerate translation of research innovations into practice.

Authors: Nearing, Kathryn Rainwater, Julie Neves, Stacey et al.

Source: Journal of Clinical & Translational Science; Jul2021, Vol. 5 Issue 1, p1-9, 9p

An update on lipid profile screening in second-generation antipsychotic users in the USA.

Authors: Morrato, Elaine H¹ (AUTHOR) elaine.morrato@ucdenver.edu

Source: Clinical Lipidology. Oct2012, Vol. 7 Issue 5, p509-523. 15p.

Communicating drug risk to physicians: Challenges and opportunities.

Authors: Morrato, Elaine H. Curbow, Barbara Crum, Rosa M. et al.

Source: International Journal of Risk & Safety in Medicine. 2008, Vol. 20 Issue 3, p143-154. 12p. 1 Diagram, 3 Charts.

Frecuencia de contacto con los profesionales sanitarios tras la advertencia de la FDA sobre el riesgo de suicidio pediátrico de los ISRS.

Authors: Morrato, Elaine H. Libby, Anne M. Orton, Heather D. et al.

Source: American Journal of Psychiatry - Edición Española. Apr2008, Vol. 11 Issue 4, p207-215. 9p. 2 Charts, 1 Graph.

Declive del tratamiento de la depresión pediátrica tras el comunicado de la FDA sobre el riesgo de suicidio con inhibidores selectivos de la recaptación de serotonina.

Authors: Libby, Anne M. Brent, David A. Morrato, Elaine H. et al.

Source: American Journal of Psychiatry - Edición Española. Sep2007, Vol. 10 Issue 8, p482-489. 8p. 1 Chart, 4 Graphs.

Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months.

Authors: Morrato, Elaine H. Lennox, Lindsay A. Sendro, Elaina R. et al.

Source: Journal of Clinical & Translational Science; Dec2020, Vol. 4 Issue 6, p515-528, 14p

Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review.

Authors: Russell, Andrea M. Morrato, Elaine H. Lovett, Rebecca M. et al.

Source: Drug Safety. May2020, Vol. 43 Issue 5, p427-446. 20p.

Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response.

Authors: Brewer, Sarah E. Campagna, Elizabeth J. Morrato, Elaine H.

Source: Journal of Clinical & Translational Science; Aug2019, Vol. 3 Issue 4, p199-209, 11p

REMS Logic Model: A Pragmatic Framework for Incorporating Drug Safety into Clinical Practice.

Authors: Toyserkani, Gita A. Robottom, Suzanne B. Morrato, Elaine H.

Source: Drug Safety. Jul2025, Vol. 48 Issue 7, p715-718. 4p.

Online resources for dissemination and implementation science: Meeting demand and lessons learned.

Authors: Ford, Bryan S. Rabin, Borsika Morrato, Elaine H. et al.

Source: Journal of Clinical & Translational Science; Oct2018, Vol. 2 Issue 5, p259-266, 8p

Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018).

Authors: Huynh, Linda Toyserkani, Gita A. Morrato, Elaine H.

Source: BMC Health Services Research. 8/6/2021, Vol. 21 Issue 1, p1-19. 19p. 8 Charts.